DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Wang S, Zhao L, Shi XJ. et al.
Development of highly potent, selective, and cellular active triazolo[1,5- a]pyrimidine-based inhibitors targeting the DCN1-UBC12 protein-protein interaction.
J Med Chem 2019;
62 (05) 2772-2797
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.